Categories AlphaGraphs, Earnings, Health Care
MEDS Earnings: Trxade Health’s net loss narrows in Q1 2023; revenue down 31%
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the first quarter of fiscal 2023. The company’s net loss narrowed from the prior-year quarter.
Revenues decreased 31% from last year to $2.2 million in the first three months of the fiscal year. The decline mainly reflects weak performance by the Trxade Prime subsidiary.
Net loss attributable to Trxade Health was $677,953 or $0.07 per share in Q1, compared to a loss of $960,147 or $0.12 per share in the same period of last year.
“We continue to focus the Company’s strategic plans and partnerships, working towards creating sustainable value for our stockholders. I am pleased with the growth we have experienced in our TRxADE platform. We continue to achieve key milestones in our internal roadmap with a focus on innovation and development through our various complementary growth opportunities,” said Trxade’s CEO Suren Ajjarapu.
Trxade’s stock has gained about 32% since the beginning of the year. The shares closed Monday’s regular trading session higher.
Stocks you may like:
Infographic: Highlights of GameStop’s Q1 2023 earnings report
Video game company GameStop Corp. (NYSE: GME) on Wednesday reported a narrower net loss for the first quarter of 2023 despite a decline in sales. The company posted a net
Adobe’s (ADBE) Q2 report is due on June 15. What to look for?
After entering the new fiscal year on an upbeat note, design software maker Adobe Inc. (NASDAQ: ADBE) is all set to report second-quarter results on June 15, after the closing
Key takeaways from Campbell Soup’s (CPB) Q3 earnings report
Shares of Campbell Soup Company (NYSE: CPB) were down 7% on Wednesday, following the announcement of the company’s third quarter 2023 earnings results. Although earnings beat projections and revenue came